Skip to content

Exelixis EXEL Business Segments — Selling, general, and administrative

Similar metrics at other companies

Biogen logo
BIIBReportable Segment — SG&A
$608.4M+1.2%
Krystal Biotech, Inc. logo
KRYSReportable Segment — SG&A
$41.01M+25.6%
Corvex
 logo
MOVESegment Reporting — Selling General And Administrative Expense
$1.49M
Medpace Holdings, Inc. logo
MEDPReportable Segment — SG&A
$47.92M-17.2%
Neurocrine Biosciences logo
NBIXReportable Segment — Selling, general, and administrative
$318.5M+15.2%
Madrigal Pharmaceuticals, Inc. logo
MDGLReportable Segment — SG&A
$239.98M+69.9%

Other financials

Income statement

See full
Revenue$610.8M+10.0%
Gross profit$590.9M+10.2%
Operating income$251.3M+34.5%
Net income$210.5M+31.9%
EPS (diluted)$0.79+43.6%

Balance sheet

See full
Cash & equivalents$226.2M+23.1%
Total debt$169.5M-9.4%
Total equity$1.9B-9.2%
Total assets$2.6B-8.6%

Cash flow

See full
Operating cash flow$251.8M+19.1%
CapEx$1.5M-48.9%
Free cash flow$250.3M+20.1%

Valuation

See full
Market cap$13.05B+10.1%
Enterprise value$12.99B+9.5%
P/E15.7×-2.8×
P/S5.5×+0.3×

Profitability

See full
Gross margin96.4%-0.3pp
Operating margin39.4%+6.3pp
Net margin35.1%+7.1pp
FCF margin38.6%+2.9pp

Returns & leverage

See full
Return on equity41%+10.8pp
Debt / equity0.1×0.0×
Current ratio3.3×-0.2×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept exel:SellingGeneralAndAdministrativeExpenseExcludingSeparateAccounts.

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's business segments — selling, general, and administrative.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exelixis's business segments — selling, general, and administrative?
Exelixis (EXEL) reported business segments — selling, general, and administrative of $122.87M in Q1 2026.
How has Exelixis's business segments — selling, general, and administrative changed year-over-year?
Exelixis's business segments — selling, general, and administrative increased by 1.7% year-over-year, from $120.78M to $122.87M.
What is the long-term trend for Exelixis's business segments — selling, general, and administrative?
Over 3 years (2022 to 2025), Exelixis's business segments — selling, general, and administrative has grown at a 3.9% compound annual growth rate (CAGR), from $397.63M to $446.54M.
What does business segments — selling, general, and administrative mean?
Operating expenses related to selling products and general corporate administration.
How do you interpret business segments — selling, general, and administrative?
An increase relative to revenue may suggest aggressive commercial expansion or inefficient administrative overhead.
How does business segments — selling, general, and administrative compare across companies?
Standard SG&A metric; common across all industries for measuring operational overhead.